PPP1R3F Inhibitors

PPP1R3F inhibitors are compounds that target and modulate the activity of the PPP1R3F protein, a regulatory subunit of protein phosphatase 1 (PP1). PP1 is a critical serine/threonine phosphatase involved in the regulation of various cellular processes, including glycogen metabolism, cell cycle progression, protein synthesis, and signal transduction pathways. The PPP1R3F subunit plays a specific role in the regulation of glycogen metabolism, particularly influencing glycogen synthesis by interacting with glycogen synthase and glycogen phosphorylase enzymes. By inhibiting PPP1R3F, these compounds effectively alter the activity of PP1 in this particular biochemical pathway, leading to changes in the balance of phosphorylation and dephosphorylation of target proteins. These changes can affect how glycogen is stored or utilized within cells, impacting various metabolic processes.

From a biochemical standpoint, PPP1R3F inhibitors are valuable tools for studying the fine-tuned mechanisms of protein phosphorylation and dephosphorylation. By inhibiting this regulatory subunit, researchers can dissect the role of PP1 in glycogen regulation more precisely, offering insights into the broader regulatory networks of cellular metabolism. Inhibition of PPP1R3F also provides a way to explore the intricate feedback loops and cross-talk between glycogen metabolism and other cellular processes, such as energy homeostasis and stress responses. Furthermore, these inhibitors serve as molecular probes for understanding how protein phosphatase complexes function dynamically in various tissues, contributing to the growing body of knowledge on phosphatase-mediated regulation in biochemistry and cell biology.